HAL vs VRCA · P/E 9.3, $19.05B cap vs rev $7.6M
Halliburton Company (HAL) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported VRCA revenue for 2024-12-31 was $7.6M. Net income was -$76.6M. Revenue was up 47.7% from 2023-12-31 to 2024-12-31. VRCA currently screens at market cap $79.7M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the HAL and VRCA stock pages for the full models.
Not investment advice.